Home/Filings/4/0001179110-19-012021
4//SEC Filing

Shafer Bradford J 4

Accession 0001179110-19-012021

CIK 0001583107other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 6:25 PM ET

Size

4.5 KB

Accession

0001179110-19-012021

Insider Transaction Report

Form 4
Period: 2019-11-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2019-11-20$17.60/sh3,567$62,779175,334 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001302448

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:25 PM ET
Size
4.5 KB